Colloidal gold preparations are less used than other gold compounds in R.A. therapy because of their doubtful efficacy. We have studied the effects of intravenously administered colloidal gold sulphide 2% on 320 patients affected with classical and definite R.A. The initial doses were 17 mg, 51 mg and 87 mg at three to five day intervals, followed by 87 mg once a week until a total dose of 1000 mg was reached. If gold proved effective the dose frequency was gradually reduced to once in four weeks. We stopped chrysotherapy only if still ineffective after 6 months or if side-effects had appeared. Our clinical experience is in agreement with the results obtained in more recent controlled trials. We observed a more frequent therapeutic effect (69%) in the early stages of disease (12 months or less) and a definite reduction in titres of rheumatoid factor.
|Number of pages||6|
|Journal||Rhumatologie - Revue International de Rhumatologie|
|Issue number||1 NO. 76|
|Publication status||Published - 1985|
ASJC Scopus subject areas